Cerus Corp

Cerus Corporation is a biomedical products company focused on blood transfusion safety. The company develops and commercializes the INTERCEPT Blood System, a pathogen-reduction platform designed to help safeguard donated blood components intended for transfusion. Its current product line includes systems for platelets and plasma, and it also supports blood centers, hospitals, and other healthcare institutions that rely on treated blood products. Cerus Corporation operates within the healthcare and medical technology markets, with its products used to reduce the risk of blood-borne pathogens while preserving the therapeutic value of transfused components. Headquartered in Concord, California, Cerus Corporation is dedicated to advancing technologies that support safer blood supply workflows across clinical settings.